These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 22608794)

  • 1. Editorial comment.
    Prasad SM; Keane TE; Bennett CL
    Urology; 2012 Jul; 80(1):168. PubMed ID: 22608794
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of prostate size on pathological outcome and biochemical recurrence after radical prostatectomy for prostate cancer: is it correlated with serum testosterone level?
    Verit A
    BJU Int; 2010 Nov; 106(10):1555. PubMed ID: 20977595
    [No Abstract]   [Full Text] [Related]  

  • 3. Editorial comment to association of prostate-specific antigen doubling time and cancer in men undergoing repeat prostate biopsy.
    Shimbo M
    Int J Urol; 2012 Aug; 19(8):747-8. PubMed ID: 22651131
    [No Abstract]   [Full Text] [Related]  

  • 4. Editorial comment.
    Schilling D; Stenzl A
    J Urol; 2010 Feb; 183(2):527-8; discussion 528. PubMed ID: 20006885
    [No Abstract]   [Full Text] [Related]  

  • 5. [Morphological and hormonal diagnosis of prostate cancer].
    Minkov N; Kumanov Kh; Tsvetkov M; Topov Ia; Maleeva A
    Khirurgiia (Sofiia); 1983; 36(3):249-51. PubMed ID: 6198553
    [No Abstract]   [Full Text] [Related]  

  • 6. Editorial comment.
    Vollmer RT
    J Urol; 2010 Mar; 183(3):1001-2. PubMed ID: 20089267
    [No Abstract]   [Full Text] [Related]  

  • 7. Editorial comment.
    Epstein JI
    J Urol; 2010 Mar; 183(3):1001. PubMed ID: 20089268
    [No Abstract]   [Full Text] [Related]  

  • 8. Editorial comment on: decision-making about PSA testing and prostate biopsies: a qualitative study embedded in a primary care randomised trial.
    Finney Rutten LJ
    Eur Urol; 2008 Jun; 53(6):1193. PubMed ID: 17709172
    [No Abstract]   [Full Text] [Related]  

  • 9. Editorial comment. Correlation between serum prostate-specific antigen and cancer volume in prostate glands of different sizes.
    Autorino R; Perdonà S; Di Lorenzo G
    Urology; 2010 Nov; 76(5):1076; author reply 1076-7. PubMed ID: 21056255
    [No Abstract]   [Full Text] [Related]  

  • 10. Low testosterone levels are related to poor prognosis factors in men with prostate cancer prior to treatment.
    Morgentaler A
    BJU Int; 2012 Dec; 110(11 Pt B):E547. PubMed ID: 22583384
    [No Abstract]   [Full Text] [Related]  

  • 11. Serum testosterone as a biomarker for second prostatic biopsy in men with negative first biopsy for prostatic cancer and PSA>4ng/mL, or with PIN biopsy result.
    Fiamegos A; Varkarakis J; Kontraros M; Karagiannis A; Chrisofos M; Barbalias D; Deliveliotis C
    Int Braz J Urol; 2016; 42(5):925-931. PubMed ID: 27532110
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Editorial comment on: Post-treatment prostate biopsies in the era of three-dimensional conformal radiotherapy: what can they teach us?
    Stanislaus P; Seitz M
    Eur Urol; 2009 Apr; 55(4):909-10. PubMed ID: 18485577
    [No Abstract]   [Full Text] [Related]  

  • 13. The importance of knowing testosterone levels in patients with prostate cancer.
    Kirby M
    BJU Int; 2014 Aug; 114(2):164-5. PubMed ID: 25070137
    [No Abstract]   [Full Text] [Related]  

  • 14. Editorial comment.
    Pastuszak AW
    J Urol; 2015 Feb; 193(2):414. PubMed ID: 25534589
    [No Abstract]   [Full Text] [Related]  

  • 15. Editorial comment.
    Mearini L
    J Urol; 2015 Feb; 193(2):414. PubMed ID: 25534585
    [No Abstract]   [Full Text] [Related]  

  • 16. Editorial comment on: Shifting the paradigm of testosterone and prostate cancer: the saturation model and the limits of androgen-dependent growth.
    Sciarra A
    Eur Urol; 2009 Feb; 55(2):320-1. PubMed ID: 18838210
    [No Abstract]   [Full Text] [Related]  

  • 17. Editorial comment on: Erectile function in prostate cancer-free patients who underwent prostate saturation biopsy.
    Badalyan R
    Eur Urol; 2008 Mar; 53(3):545-6. PubMed ID: 17619080
    [No Abstract]   [Full Text] [Related]  

  • 18. Editorial comment. Focal positive surgical margins decrease disease-free survival after radical prostatectomy even in organ-confined disease.
    Soloway MS
    Urology; 2010 Nov; 76(5):1216-7. PubMed ID: 21056271
    [No Abstract]   [Full Text] [Related]  

  • 19. Editorial comment on: Shifting the paradigm of testosterone and prostate cancer: the saturation model and the limits of androgen-dependent growth.
    Tombal B
    Eur Urol; 2009 Feb; 55(2):321. PubMed ID: 18838209
    [No Abstract]   [Full Text] [Related]  

  • 20. Pretreatment testosterone and metastatic relapse after prostate irradiation.
    Daniell HW
    Urology; 1999 Jan; 53(1):241. PubMed ID: 9886624
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.